Your session is about to expire
← Back to Search
Intranasal Oxytocin for Autism Spectrum Disorder
Study Summary
This trial tests oxytocin nasal spray as a treatment for social impairment in adolescents with ASD. The hypothesis is that oxytocin nasal spray will be safe, tolerable, and effective in improving the core symptoms of ASD in adolescents ages 11-17.
- Autism Spectrum Disorder
- Pervasive Developmental Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 & 3 trial • 43 Patients • NCT02255357Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many people have signed up to be a part of this research project?
"This study is not recruiting patients at the moment. The clinical trial was originally advertised on October 1st, 2013 and updated for the final time on July 29th, 2022. However, there are presently 1194 other clinical trials actively enrolling patients with autism spectrum disorder and 57 trials for Intranasal Oxytocin that are still looking for participants."
What therapeutic effects does Intranasal Oxytocin generally provide?
"Oxytocin, which can be administered intranasally, is often used to treat hemorrhage. However, it has also been effective in other medical situations such as uterine contractions during labor and reinforcement of labor."
Does this research exclude people who are over a certain age?
"This research is enrolling those who are pre-pubescent to early adolescence, aged 11 through 17."
How can I sign up for the research project?
"This autism spectrum disorder clinical trial requires that potential participants be between 11 and 17 years old. The team is looking for approximately 40 individuals to take part in the study."
Are researchers still enrolling people for this trial?
"As of 7/29/2022, this clinical trial is no longer actively recruiting patients. If you are interested in other trials, there are 1194 active autism spectrum disorder studies and 57 Intranasal Oxytocin trials currently enrolling participants."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger